...
首页> 外文期刊>Molecular Immunology >A new strategy for enhancing antitumor immune response using dendritic cells loaded with chemo-resistant cancer stem-like cells in experimental mice model
【24h】

A new strategy for enhancing antitumor immune response using dendritic cells loaded with chemo-resistant cancer stem-like cells in experimental mice model

机译:使用在实验性小鼠模型中使用中抗性癌症干细胞的树突细胞增强抗肿瘤免疫应答的新策略

获取原文
获取原文并翻译 | 示例
           

摘要

Background and aim: Cancer stem cells (CSCs) are rare cell population present in the tumor bulk that are thought to be the reason for treatment failure following chemotherapy in terms of their intrinsic chemo-resistance. Our study aimed to develop an effective therapeutic strategy to target chemo-resistant cancer stem - like cells population in solid Ehrlich carcinoma (SEC) mice model using dendritic cells (DCs) loaded with enriched tumor cells lysate bearing CSC-like phenotype as a vaccine.
机译:背景和目的:癌症干细胞(CSCs)是肿瘤批量中存在的稀有细胞群,被认为是在其内在化学抗性方面进行化疗后治疗失败的原因。 我们的研究旨在使用含有富含CSC的肿瘤细胞裂解物含有CSC样表型作为疫苗的树突状细胞(DC)来制定有效的治疗策略,以靶向固体EHRLICH癌(SEC)小鼠模型中的固体EHRLICH癌(SEC)小鼠模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号